methylene blue has been researched along with Acute Post-Traumatic Stress Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bluett, EJ; Cobb, A; Farach, FJ; Foa, EB; Gallop, R; Gonzalez-Lima, F; McLean, CP; Telch, M; Zoellner, LA | 1 |
| Lonak, SF; Marin, MF; Milad, MR | 1 |
1 review(s) available for methylene blue and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety Disorders; Cycloserine; Endocannabinoids; Estrogens; Evidence-Based Medicine; Histone Deacetylase Inhibitors; Humans; Methylene Blue; Nootropic Agents; Psychotherapy; Stress Disorders, Post-Traumatic | 2015 |
1 trial(s) available for methylene blue and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.
Topics: Adult; Chronic Disease; Combined Modality Therapy; Extinction, Psychological; Female; Follow-Up Studies; Humans; Implosive Therapy; Interview, Psychological; Male; Methylene Blue; Middle Aged; Patient Dropouts; Psychotherapy, Brief; Quality of Life; Stress Disorders, Post-Traumatic; Treatment Outcome | 2017 |